Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2025 Filed Jun 6, 2025 20:27 UTC |
Smith David VDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002034 · form4.xml · derivative · entry 1 Smith David V · CIK 0001229447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:27 UTC |
Hunter HeidiDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002033 · form4.xml · derivative · entry 1 Hunter Heidi · CIK 0001891841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:26 UTC |
Hirth PeterDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002032 · form4.xml · derivative · entry 1 Hirth Peter · CIK 0001813780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:26 UTC |
Glaub Kathleen SeredaDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002031 · form4.xml · derivative · entry 1 Glaub Kathleen Sereda · CIK 0001619612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:25 UTC |
Elling Christian EDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002030 · form4.xml · derivative · entry 1 Elling Christian E · CIK 0001891306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:24 UTC |
Collins Helen LouiseDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,144 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000905148-25-002029 · form4.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,144 Underlying: Common Stock · 35,144 shares Expires 2035-06-05 F1 · derivative.exercise_date: These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 11:53 UTC |
Hunter HeidiDirector
|
PurchaseCommon Stock | 15,000 | $1.39 | $20,884.50 |
DisclosureSEC source: 0000905148-25-001960 · form4.xml · nonDerivative · entry 1 Hunter Heidi · CIK 0001891841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The transaction was executed in multiple trades in prices ranging from $1.37 to $1.40, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 16:18 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 580,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000905148-25-001096 · form4.xml · derivative · entry 1 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,000 Underlying: Common Stock · 580,000 shares Expires 2035-04-02 F1 · derivative.exercise_date: One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:12 UTC |
Burkavage BrianChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000905148-25-001093 · form4.xml · derivative · entry 1 Burkavage Brian · CIK 0001865633 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2035-04-02 F1 · derivative.exercise_date: One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:16 UTC |
Sullivan AmyChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000905148-25-001095 · form4.xml · derivative · entry 1 Sullivan Amy · CIK 0001887865 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2035-04-02 F1 · derivative.exercise_date: One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:13 UTC |
Smith Devin WhittemoreGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000905148-25-001094 · form4.xml · derivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2035-04-02 F1 · derivative.exercise_date: One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:09 UTC |
Ahmad Qasim IftikharChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000905148-25-001092 · form4.xml · derivative · entry 1 Ahmad Qasim Iftikhar · CIK 0001985801 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2035-04-02 F1 · derivative.exercise_date: One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| December 23, 2024 Filed Dec 23, 2024 18:56 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
PurchaseCommon Stock | 12,500 | $0.81 | $10,120.00 |
DisclosureSEC source: 0000905148-24-003412 · form4.xml · nonDerivative · entry 1 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,891 F1 · price: The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations. Read SEC document |
| December 23, 2024 Filed Dec 23, 2024 23:53 UTC |
Sullivan AmyChief Financial Officer
|
PurchaseCommon Stock | 10,250 | $0.83 | $8,482.90 |
DisclosureSEC source: 0000905148-24-003410 · form4.xml · nonDerivative · entry 1 Sullivan Amy · CIK 0001887865 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,632 F1 · price: The transaction was executed in multiple trades in prices ranging from $0.7861 to $0.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 23, 2024 Filed Dec 23, 2024 23:52 UTC |
Smith Devin WhittemoreGeneral Counsel
|
PurchaseCommon Stock | 12,000 | $0.81 | $9,720.00 |
DisclosureSEC source: 0000905148-24-003408 · form4.xml · nonDerivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,938 Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 13:50 UTC |
Ahmad Qasim IftikharChief Medical Officer
|
PurchaseCommon Stock | 31,350 | $0.85 | $26,553.45 |
DisclosureSEC source: 0000905148-24-003414 · form4.xml · nonDerivative · entry 1 Ahmad Qasim Iftikhar · CIK 0001985801 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,350 Read SEC document |
| July 26, 2024 Filed Jul 27, 2024 01:22 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCOMMON STOCK | 23,478 | $1.31 | $30,786.70 |
DisclosureSEC source: 0000950170-24-087061 · ownership.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,354,449 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 25, 2024 Filed Jul 27, 2024 01:22 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCOMMON STOCK | 51,522 | $1.33 | $68,338.78 |
DisclosureSEC source: 0000950170-24-087061 · ownership.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,377,927 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:19 UTC |
Smith David VDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001687 · form4.xml · derivative · entry 1 Smith David V · CIK 0001229447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:17 UTC |
Hirth PeterDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001685 · form4.xml · derivative · entry 1 Hirth Peter · CIK 0001813780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:18 UTC |
Hunter HeidiDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001686 · form4.xml · derivative · entry 1 Hunter Heidi · CIK 0001891841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:16 UTC |
Glaub Kathleen SeredaDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001684 · form4.xml · derivative · entry 1 Glaub Kathleen Sereda · CIK 0001619612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:12 UTC |
Collins Helen LouiseDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001682 · form4.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:14 UTC |
Elling Christian EDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,642 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000905148-24-001683 · form4.xml · derivative · entry 1 Elling Christian E · CIK 0001891306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,642 Underlying: Common Stock · 45,642 shares Expires 2034-06-06 F1 · derivative.exercise_date: These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| May 10, 2024 Filed May 15, 2024 01:13 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCOMMON STOCK | 658,809 | $1.22 | $802,495.24 |
DisclosureSEC source: 0000950170-24-059965 · ownership.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,429,449 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 16:27 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 750,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000905148-24-000970 · form4.xml · derivative · entry 1 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:22 UTC |
Burkavage BrianChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000905148-24-000967 · form4.xml · derivative · entry 1 Burkavage Brian · CIK 0001865633 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:24 UTC |
Sullivan AmyChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000905148-24-000969 · form4.xml · derivative · entry 1 Sullivan Amy · CIK 0001887865 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:23 UTC |
Smith Devin WhittemoreGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 185,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000905148-24-000968 · form4.xml · derivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:18 UTC |
Ahmad Qasim IftikharChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000905148-24-000966 · form4.xml · derivative · entry 1 Ahmad Qasim Iftikhar · CIK 0001985801 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:31 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCOMMON STOCK | 658,809 | $1.50 | $988,411.14 |
DisclosureSEC source: 0001209191-24-003303 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,088,258 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 22, 2023 Filed Nov 24, 2023 22:37 UTC |
Burkavage BrianChief Accounting Officer
|
PurchaseCommon Stock | 5,000 | $1.04 | $5,175.00 |
DisclosureSEC source: 0000905148-23-001527 · form4.xml · nonDerivative · entry 2 Burkavage Brian · CIK 0001865633 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 F1 · price: The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 22:37 UTC |
Burkavage BrianChief Accounting Officer
|
PurchaseCommon Stock | 5,000 | $0.99 | $4,950.00 |
DisclosureSEC source: 0000905148-23-001527 · form4.xml · nonDerivative · entry 1 Burkavage Brian · CIK 0001865633 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:47 UTC |
Collins Helen LouiseDirector
|
GrantStock Option (Right to Buy) · Derivative | 64,238 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000905148-23-001485 · form4.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,238 Underlying: Common Stock · 64,238 shares Expires 2033-11-15 F1 · derivative.exercise_date: 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 22:02 UTC |
Hunter HeidiDirector
|
GrantStock Option (Right to Buy) · Derivative | 64,238 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001140361-23-039937 · form4.xml · derivative · entry 1 Hunter Heidi · CIK 0001891841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,238 Underlying: Common Stock · 64,238 shares Expires 2033-08-11 F1 · derivative.exercise_date: 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:43 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
GrantWarrants (Right to Buy) · Derivative | 37,037 | $0.13 Strike: $2.47 | $4,629.63 |
DisclosureSEC source: 0001140361-23-038881 · form4.xml · derivative · entry 3 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,037 Underlying: Common Stock · 37,037 shares Expires not disclosed F2 · derivative.expiration_date: These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:43 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
GrantCommon Stock | 37,037 | $1.90 | $70,370.30 |
DisclosureSEC source: 0001140361-23-038881 · form4.xml · nonDerivative · entry 1 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,391 Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 00:41 UTC |
Sullivan AmyChief Financial Officer
|
GrantWarrants (Right to Buy) · Derivative | 49,382 | $0.13 Strike: $2.47 | $6,172.75 |
DisclosureSEC source: 0001140361-23-038879 · form4.xml · derivative · entry 2 Sullivan Amy · CIK 0001887865 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,382 Underlying: Common Stock · 49,382 shares Expires not disclosed F1 · derivative.expiration_date: These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 00:41 UTC |
Sullivan AmyChief Financial Officer
|
GrantCommon Stock | 49,382 | $1.90 | $93,825.80 |
DisclosureSEC source: 0001140361-23-038879 · form4.xml · nonDerivative · entry 1 Sullivan Amy · CIK 0001887865 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,382 Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 00:38 UTC |
Smith Devin WhittemoreGeneral Counsel
|
GrantWarrants (Right to Buy) · Derivative | 4,938 | $0.13 Strike: $2.47 | $617.25 |
DisclosureSEC source: 0001140361-23-038877 · form4.xml · derivative · entry 2 Smith Devin Whittemore · CIK 0001747818 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,938 Underlying: Common Stock · 4,938 shares Expires not disclosed F1 · derivative.expiration_date: These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 00:38 UTC |
Smith Devin WhittemoreGeneral Counsel
|
GrantCommon Stock | 4,938 | $1.90 | $9,382.20 |
DisclosureSEC source: 0001140361-23-038877 · form4.xml · nonDerivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,938 Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 13:03 UTC |
Vivo Capital IX, LLC10% owner
Vivo Capital Fund IX, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund Holdings, L.P.10% owner
|
PurchaseWarrants (Right to Buy) · Derivative | 3,157,894 | $0.13 Strike: $2.47 | $394,736.75 |
DisclosureSEC source: 0001213900-23-065297 · ownership.xml · derivative · entry 3 Vivo Capital IX, LLC · CIK 0001750698 · 10% owner Vivo Capital Fund IX, L.P. · CIK 0001750117 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund Holdings, L.P. · CIK 0001930214 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Vivo Opportunity Fund Holdings, L.P. Disclosed balance after: 3,157,894 Underlying: Common Stock · 3,157,894 shares Expires not disclosed F1 · kind: Purchase was made pursuant to that certain Securities Purchase Agreement dated as of August 7, 2023, by and among the Issuer and the purchasers named therein. F3 · derivative.exercise_date: These warrants expire at 5:00 p.m. on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023, provided that the holder will be prohibited from exercising these warrants if, after giving effect to such exercise, the holder (together with such holder's affiliates and any other persons acting as a group together) would beneficially own in excess of 9.99% of the shares of common stock of the Issuer outstanding immediately after giving effect to such exercise. F3 · derivative.expiration_date: These warrants expire at 5:00 p.m. on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023, provided that the holder will be prohibited from exercising these warrants if, after giving effect to such exercise, the holder (together with such holder's affiliates and any other persons acting as a group together) would beneficially own in excess of 9.99% of the shares of common stock of the Issuer outstanding immediately after giving effect to such exercise. F2 · ownership.nature: The securities are held directly by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As the managing members of Vivo Opportunity, LLC, Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P., but each disclaims beneficial ownership of such securities except to the extent of their individual pecuniary interest therein. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 13:03 UTC |
Vivo Capital IX, LLC10% owner
Vivo Capital Fund IX, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund Holdings, L.P.10% owner
|
PurchaseCommon Stock | 3,157,894 | $1.90 | $5,999,998.60 |
DisclosureSEC source: 0001213900-23-065297 · ownership.xml · nonDerivative · entry 1 Vivo Capital IX, LLC · CIK 0001750698 · 10% owner Vivo Capital Fund IX, L.P. · CIK 0001750117 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund Holdings, L.P. · CIK 0001930214 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Vivo Opportunity Fund Holdings, L.P. Disclosed balance after: 3,157,894 F1 · kind: Purchase was made pursuant to that certain Securities Purchase Agreement dated as of August 7, 2023, by and among the Issuer and the purchasers named therein. F2 · ownership.nature: The securities are held directly by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As the managing members of Vivo Opportunity, LLC, Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P., but each disclaims beneficial ownership of such securities except to the extent of their individual pecuniary interest therein. Read SEC document |
| August 09, 2023 Filed Aug 12, 2023 01:22 UTC |
Lundbeckfond Invest A/SDirector · 10% owner
|
GrantWarrants (Right to Buy) · Derivative | 7,901,234 | $0.13 Strike: $2.47 | $987,654.25 |
DisclosureSEC source: 0001140361-23-039344 · form4.xml · derivative · entry 2 Lundbeckfond Invest A/S · CIK 0001591046 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,901,234 Underlying: Common Stock · 7,901,234 shares Expires not disclosed F1 · derivative.expiration_date: These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023). Read SEC document |
| August 09, 2023 Filed Aug 12, 2023 01:22 UTC |
Lundbeckfond Invest A/SDirector · 10% owner
|
GrantCommon Stock | 7,901,234 | $1.90 | $15,012,344.60 |
DisclosureSEC source: 0001140361-23-039344 · form4.xml · nonDerivative · entry 1 Lundbeckfond Invest A/S · CIK 0001591046 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,950,686 Read SEC document |
| August 09, 2023 Filed Aug 12, 2023 01:24 UTC |
Elling Christian EDirector · 10% owner
|
GrantWarrants (Right to Buy) · Derivative | 7,901,234 | $0.13 Strike: $2.47 | $987,654.25 |
DisclosureSEC source: 0001140361-23-039346 · form4.xml · derivative · entry 2 Elling Christian E · CIK 0001891306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Lundbeckfond Invest A/S Disclosed balance after: 7,901,234 Underlying: Common Stock · 7,901,234 shares Expires not disclosed F2 · derivative.expiration_date: These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023). F1 · ownership.nature: The securities are held of record by Lundbeckfond Invest A/S. The Reporting Person is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S. The Reporting Person disclaims beneficial ownership of the securities held by Lundbeckfond Invest A/S except to the extent of his pecuniary interest therein, if any. Read SEC document |
| August 09, 2023 Filed Aug 12, 2023 01:24 UTC |
Elling Christian EDirector · 10% owner
|
GrantCommon Stock | 7,901,234 | $1.90 | $15,012,344.60 |
DisclosureSEC source: 0001140361-23-039346 · form4.xml · nonDerivative · entry 1 Elling Christian E · CIK 0001891306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Lundbeckfond Invest A/S Disclosed balance after: 13,950,686 F1 · ownership.nature: The securities are held of record by Lundbeckfond Invest A/S. The Reporting Person is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S. The Reporting Person disclaims beneficial ownership of the securities held by Lundbeckfond Invest A/S except to the extent of his pecuniary interest therein, if any. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
PurchaseCommon Stock Warrant (Right to Buy) · Derivative | 2,469,135 | $2.03 Strike: $2.47 | $4,999,998.38 |
DisclosureSEC source: 0001209191-23-045444 · doc4.xml · derivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,469,135 Underlying: Common Stock · 2,469,135 shares Expires 2027-02-09 F1 · price: Represents a combined purchase price of $2.025 for Common Stock and Warrants from Issuer in a private placement. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
PurchaseCommon Stock | 2,469,135 | $2.03 | $4,999,998.38 |
DisclosureSEC source: 0001209191-23-045444 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,707,467 F1 · price: Represents a combined purchase price of $2.025 for Common Stock and Warrants from Issuer in a private placement. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:20 UTC |
Ahmad Qasim IftikharChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 288,153 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001140361-23-035207 · form4.xml · derivative · entry 1 Ahmad Qasim Iftikhar · CIK 0001985801 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,153 Underlying: Common Stock · 288,153 shares Expires 2033-07-17 F1 · derivative.exercise_date: One-fourth of these options vest on July 17, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.